Literature DB >> 32234315

The ability of miRNAs to induce mesenchymal-to-epithelial transition (MET) in cancer cells is highly dependent upon genetic background.

Mengnan Zhang1, Yuehua Wang2, Lilya V Matyunina3, Amber Akbar4, John F McDonald5.   

Abstract

Understanding of the molecular basis of host cell-miRNA interactions is prerequisite to the successful application of miRNAs as potential therapeutic agents. We studied the morphological and molecular consequences of over expression of three sequence divergent miRNAs previously implicated in the mesenchymal-to-epithelial transition process (MET) in three distinct mesenchymal-like cancer cell lines. The ability of miRNAs to induce morphological changes characteristic of MET positively correlated with induced changes in the expression of genes previously implicated in the process. Variability in the responses of different mesenchymal-like cells to over expression of the same miRNAs was attributable to inherent differences in trans-regulatory profiles pre-disposing these cells to miRNA-induced MET. Collectively our results indicate that miRNA-mediated regulation of MET is a highly integrated process that is significantly modulated by the molecular background of individual cells.
Copyright © 2020 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer; Gene expression; Mesenchymal-to-epithelial transition (MET); miRNA

Mesh:

Substances:

Year:  2020        PMID: 32234315     DOI: 10.1016/j.canlet.2020.03.023

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  2 in total

1.  Silencing of Long Non-Coding RNA LINC01106 Suppresses the Proliferation, Migration and Invasion of Endometrial Cancer Cells Through Regulating the miR-449a/MET Axis.

Authors:  Xihuan Gao; Liming Yu; Jingjing Zhang; Ping Xue
Journal:  Onco Targets Ther       Date:  2020-09-29       Impact factor: 4.147

2.  MicroRNA-375-3p Suppresses Upper Tract Urothelial Carcinoma Cell Migration and Invasion via Targeting Derlin-1.

Authors:  Jhen-Hao Jhan; Wei-Chi Hsu; Yi-Chen Lee; Wei-Ming Li; A-Mei Huang; Hui-Hui Lin; Chien-Sheng Wang; Yi-Ru Wu; Ching-Chia Li; Wen-Jeng Wu; Hung-Lung Ke
Journal:  Cancers (Basel)       Date:  2022-02-10       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.